Comparative Study on Expression of β-catenin in Hunman Advanced Colorectal Carcinoma and Metastatic Lymph Nodes
Wang Feng-an
Abstract
Wang Feng-an
Abstract
Objective To investigate the expression of β-catenin mRNA and protein in hunman advanced colorectal cancer and their metastatic lymph nodes,discuss the correlation between the expression of β-catenin and the biological behaviour of colorectal cancer,and explore a new possible target on molecular level to diagnose and treat colorectal cancer.Methods The methods of immunohistochemical staining,semiquantitative RT-PCR and western blot were used to detect and compare the expressions of β-cat mRNA and protein in 45 cases of human advanced colorectal cancer and their metastatic lymph nodes.And the mechanism by wich β-cat reexpress in metastatic lymph nodes of colorectal cancer was explored.Results The re-expression level of β-cat in metastatic lymph nodes was closely related to the differentiating degree and histological type of tumor.(1) Immunohistochemical results:the abnormal expression rate of β-cat was 80%(36/45) in 45 primary tumors of human advanced colorectal cancers,and the re-expression rate of β-cat in metastatic lymph nodes was 40%(18/45) .The re-expression rate ofβ-cat in well-differentiated colorectal cancer was significantly higher than that in poorly differentiated,54.2%(13/24) versus 23.8%(5/21) .The re-expression rate of β-cat in metastatic lymph nodes of tubular or papillary adenocarcinoma and mucinous adenocarcinoma was 35.7%(10/28) and 47.1%(8/17) ,respectively.The re-expression rate of β-cat in metastatic lymph nodes was independent with the tumor location,invasion depth,and the gender and age of patients.(2) RT-PCR results:There were different expression levels ofβ-cat mRNA in 45 cases of hunman advanced colorectal cancers and their metastatic lymph nodes.The relative expression value of β-cat mRNA in colorectal cancers was(0.724±0.006) ,which was significantly lower than that in the normal colorectal mucosa(0.785±0.017,t=21.066,P0.01) .The relative expression value of β-cat mRNA in metastatic lymph nodes was significantly higher than that in primarily focus,and significantly lower than that in normal colorectal mucosa.At the same time,the expressions ofβ-cat mRNA in metastatic lymph nodes were significantly correlated with the differentiating degree and histological type of tumor.(3) Western-blot results:There wereβ-cat protein expression in all the 25 cases of normal colorectal mucosa,while the different levels of β-cat protein expression were detected in 41 cases of primary tumors and the corresponding metastatic lymph nodes of total 45 cases.The β-cat protein expression was not detected in the primary tumors of 4 cases of colorectal cancer,but was detected in the metastatic lymph nodes of one of the four cases of colorectal cancer.The relative strength of β-cat protein in primary tumors was 6~108(54.3±38.1) in 41 cases of colorectal cancer,which was significantly lower than that in normal colorectal mucous membrane 15~172(95.4±49.8) .The β-cat protein expression in metastatic lymph nodes was significantly higher than that in primary focus,but was lower than in the normal colorectal mucosa.In metastatic lymph nodes from well-differentiated and moderately differentiated primary cancers,the relative intensity of β-cat protein expression were significantly higher than that from poorly differentiated cancers.Theβ-cat protein expression in tubular or papillary adenocarcinoma was significantly higher than that in mucinous adenocarcinoma.Conclusions In the development and progression of colorectal cancer,there is a certain changing characteristics of β-cat expression in the gene and protein levels.The characteristics make β-cat possible to become a new target for the diagnosis and treatment of colorectal cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the expression of β-catenin mRNA and protein in hunman advanced colorectal cancer and their metastatic lymph nodes,discuss the correlation between the expression of β-catenin and the biological behaviour of colorectal cancer,and explore a new possible target on molecular level to diagnose and treat colorectal cancer.Methods The methods of immunohistochemical staining,semiquantitative RT-PCR and western blot were used to detect and compare the expressions of β-cat mRNA and protein in 45 cases of human advanced colorectal cancer and their metastatic lymph nodes.And the mechanism by wich β-cat reexpress in metastatic lymph nodes of colorectal cancer was explored.Results The re-expression level of β-cat in metastatic lymph nodes was closely related to the differentiating degree and histological type of tumor.(1) Immunohistochemical results:the abnormal expression rate of β-cat was 80%(36/45) in 45 primary tumors of human advanced colorectal cancers,and the re-expression rate of β-cat in metastatic lymph nodes was 40%(18/45) .The re-expression rate ofβ-cat in well-differentiated colorectal cancer was significantly higher than that in poorly differentiated,54.2%(13/24) versus 23.8%(5/21) .The re-expression rate of β-cat in metastatic lymph nodes of tubular or papillary adenocarcinoma and mucinous adenocarcinoma was 35.7%(10/28) and 47.1%(8/17) ,respectively.The re-expression rate of β-cat in metastatic lymph nodes was independent with the tumor location,invasion depth,and the gender and age of patients.(2) RT-PCR results:There were different expression levels ofβ-cat mRNA in 45 cases of hunman advanced colorectal cancers and their metastatic lymph nodes.The relative expression value of β-cat mRNA in colorectal cancers was(0.724±0.006) ,which was significantly lower than that in the normal colorectal mucosa(0.785±0.017,t=21.066,P0.01) .The relative expression value of β-cat mRNA in metastatic lymph nodes was significantly higher than that in primarily focus,and significantly lower than that in normal colorectal mucosa.At the same time,the expressions ofβ-cat mRNA in metastatic lymph nodes were significantly correlated with the differentiating degree and histological type of tumor.(3) Western-blot results:There wereβ-cat protein expression in all the 25 cases of normal colorectal mucosa,while the different levels of β-cat protein expression were detected in 41 cases of primary tumors and the corresponding metastatic lymph nodes of total 45 cases.The β-cat protein expression was not detected in the primary tumors of 4 cases of colorectal cancer,but was detected in the metastatic lymph nodes of one of the four cases of colorectal cancer.The relative strength of β-cat protein in primary tumors was 6~108(54.3±38.1) in 41 cases of colorectal cancer,which was significantly lower than that in normal colorectal mucous membrane 15~172(95.4±49.8) .The β-cat protein expression in metastatic lymph nodes was significantly higher than that in primary focus,but was lower than in the normal colorectal mucosa.In metastatic lymph nodes from well-differentiated and moderately differentiated primary cancers,the relative intensity of β-cat protein expression were significantly higher than that from poorly differentiated cancers.Theβ-cat protein expression in tubular or papillary adenocarcinoma was significantly higher than that in mucinous adenocarcinoma.Conclusions In the development and progression of colorectal cancer,there is a certain changing characteristics of β-cat expression in the gene and protein levels.The characteristics make β-cat possible to become a new target for the diagnosis and treatment of colorectal cancer.
Key concepts: Lymph, Colorectal cancer, Medicine, Immunohistochemistry, Adenocarcinoma, Pathology, Colorectal adenocarcinoma, Metastasis